COVID-19 vaccination during the 2024-2025 respiratory virus season was associated with protection against hospitalization.

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had ...

The American College of Physicians (ACP) has recommended that adults aged 65 years or older receive updated 2025–2026 mRNA-based COVID-19 vaccines, according to February guidelines published in Annals ...

Ongoing studies indicate that maternal COVID-19 vaccinations do not have any significant impact on prenatal neurodevelopment.

German biopharmaceutical company BioNTech sued Moderna ​in Delaware federal court on Thursday, alleging that Moderna's ...

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, relies on proprietary technology developed and ...

Among women who never got sick, researchers found the shots appeared to improve vascular and immune health. For mothers with ...

Moderna (MRNA) stock is in focus as BioNTech (BNTX) sues the biotech for allegedly violating patent linked to the rival shot developed with Pfizer (PFE). Read more here.

Scientists say the world is now a significant step closer to developing a universal vaccine that could protect against common ...

The company revised its plan to seek full approval for middle-aged adults and accelerated approval for seniors.